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Abstract
Background Neurological emergencies are common and
frequently devastating. Every year, millions of Americans
suffer an acute stroke, severe traumatic brain injury, sub-
arachnoidhemorrhage,statusepilepticus,orspinalcordinjury
severe enough to require medical intervention.
Aims Full evaluation of the diseases in the acute setting often
requires advanced diagnostics, and treatment frequently
necessitates transfer to specialized centers. Delays in diagno-
sis and/or treatment may result in worsened outcomes;
therefore, optimization of diagnostics is critical.
Methods Point-of-care (POC) testing brings advanced diag-
nostics to the patient’s bedside in an effort to assist medical
providers with real-time decisions based on real-time infor-
mation. POC testing is usually associated with blood tests
(blood glucose, troponin, etc.), but can involve imaging,
medical devices, or adapting existing technologies for use
outside of the hospital. Noticeably missing from the list of
current point-of-care technologies are real-time bedside
capabilities that address neurological emergencies.
Results Unfortunately, the lack of these technologies may
result in delayed identification of patients of these devastating
conditions and contribute to less aggressive therapies than is
seen with other disease processes. Development of time-
dependent technologies appropriate for use with the neurolog-
ically ill patient are needed to improvetherapies and outcomes.
Conclusion POC-CENT is designed to support the develop-
ment of novel ideas focused on improving diagnostic or
prognostic capabilities for acute neurological emergencies.
Eligible examples include biomarkers of traumatic brain
injury, non-invasive measurements of intracranial pressure
or cerebral vasospasm, and improved detection of patholog-
ical bacteria in suspected meningitis.
Keywords Point-of-care systems.Neurology.Diagnostic
techniques, neurological.Emergency medicine.Brain.
Critical care
Neurological emergencies are common and frequently dev-
astating. Every year, millions of Americans suffer an acute
stroke, severe traumatic brain injury, subarachnoid hemor-
rhage, status epilepticus, or spinal cord injury severe enough
to require medical intervention [1–10]. Full evaluation of the
diseases in the acute setting often requires advanced
diagnostics, and treatment frequently necessitates transfer to
specialized centers. Delays in diagnosis and/or treatment
may result in worsened outcomes therefore optimization of
diagnostics is critical.
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Worldwide, acute ischemic stroke affects millions of people
every year, causing significant morbidity and mortality; in the
US, a person suffers a stroke every 40 s, and a stroke death
occurs every 4 min [2]. The annual age-adjusted incidence
per 100,000 population is 105–262 in India [11] and 140.1/
100,000 in Chile [12], compared to 158/100,000 in the US
[2]. The use of recombinant rt-PA is strictly limited by time,
and a large number of patients present outside the window
for treatment. Even for those who are treated, functional
outcome and the time interval between stroke symptom
onset and drug administration are inversely related (Fig. 1)
[13, 14].
Treatment decisions require non-contrast computed
tomography (CT) to rule out intracranial hemorrhage; other
stroke mimics are not uncommon [15]. While CT technol-
ogy is readily available in most cities, rural settings and
developing countries may not have rapid guaranteed access
to this diagnostic tool or the skilled personnel to interpret
the images. Even when CT is available, time is dedicated to
the acquisition and interpretation of the images before
treatment can begin, causing an unavoidable and highly
variable delay in therapy.
Alternative techniques that can assist in real-time
diagnostic separation of ischemic from hemorrhagic
strokes, with minimal subjective interpretation, are needed.
Such novel methods could speed time to therapy or increase
the number of stroke patients who would be eligible for
treatment, thereby improving outcomes. This technology
could serve to differentiate likely candidates from unlikely
candidates and aid in prioritization of CT scans. In addition,
diagnostics could be translated into the pre-hospital setting,
allowing Emergency Medical Services to triage patients to
the most appropriate facilities—subjects with intracranial
hemorrhage could be taken to neurosurgical capable
facilities, while those with ischemic stroke could be taken
to the closest appropriate facility for rt-PA administration.
Uncoupling the reliance on CT to determine treatment
could, one day, allow outside-of-hospital therapy options as
many stroke victims first present to primary care physician
offices or face prolonged ambulance transport times [16].
Pre-hospital systems that utilize physicians could, one day,
administer rt-PA prior to hospital arrival if hemorrhagic
stroke could be excluded, or ischemic infarction definitive-
ly diagnosed, with point-of-care technologies.
The fear of causing intracranial hemorrhage is often cited
asareasonwhythrombolytictherapyisnotofferedbytreating
physicians [17, 18]. Advanced age, duration of symptoms,
and severity of stroke increase the risk of hemorrhage.
Hemorrhagic transformation of ischemic stroke with the use
of rt-PA remains unpredictable in individual scenarios [19],
and treatment response and clinical improvement are
variable. The result is that clinicians can only offer an
educated guess of the chance of recovery or worsening for
individual patients based on treatment choices. A real-time,
point-of-care test that will better predict risk of hemorrhage
or probability of good response to therapy with the expected
benefit of decreasing fear and risk of intracranial hemorrhage
is needed for these clinical scenarios. These tests could help
health care providers, patients, and families weigh true risk-
benefit ratios when deciding a treatment course.
Non-convulsive status epilepticus
Non-convulsive status epilepticus (NSCE) is a challenging
clinical diagnosis with potentially devastating consequences
if untreated [20]. Like convulsive status epilepticus, non-
convulsive seizures are more likely to be controlled when
treated early, and the length of seizure activity is correlated
with poor outcomes [21–23]. NCSE may be present in
patients with unexplained coma or altered mental status;
some patients may be able to follow commands despite
epileptic activity on EEG [24]. This is of special concern in
critically ill patients and may complicate the course of up to
halfofthoseinacoma[24, 25]. NCSE is prevalent in patients
with traumatic brain injury, subarachnoid hemorrhage,
hemorrhagic and ischemic stroke, and cerebral malignancy,
where these seizures may contribute to secondary injuries
and worsened outcomes [26]. NCSE may mimic acute
ischemic stroke [27], and such patients are occasionally
treated with rt-PA. Differentiating NCSE from acute stroke
would minimize such treatments and decrease concomitant
risks associated with rt-PA administration.
Currently, diagnosis of non-convulsive status requires
continuous EEG monitoring, which is generally only
Fig. 1 Odds ratio of favorable outcome after acute ischemic stroke is
dependent on symptom onset to rT-pa treatment interval. (Borrowed
with permission from Hacke W, Donnan G, Fieschi C, Kaste M, von
Kummer R, Broderick JP, et al. Association of outcome with early
stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS
rt-PA stroke trials. Lancet 2004;363(9411):768–74)
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the time required to place electrodes and the resources
needed to provide skilled monitoring and interpretation
make continuous EEG monitoring onerous in most centers.
Because treatment and recovery are time-dependent and
diagnosis is difficult, alternatives to traditional EEG
monitoring are needed. Point-of-care diagnostics with easy
to interpret and real-time results could improve the care of
many patients.
Suspected traumatic brain injury
Altered mental status after trauma is common, but does not
always represent a traumatic brain injury (TBI). In some
cases, pre-existing medical conditions, antecedent medical
emergencies, or intoxicants cloud the clinical picture.
Mechanism of injury is not a reliable predictor of underlying
injuries, and Emergency Medical Services frequently over-
triage these patients to designated Trauma Centers [28].
Helicopter transport from a trauma scene is often requested
due to suspicion of possible TBI for patients who ultimately
do not have significant injuries [28]. Emergency Depart-
ments often obtain head CTs that ultimately prove to be
normal, and existing clinical decision rules have not
diminished this practice because of broad inclusion criteria
and a reluctance to miss high morbidity injuries [29, 30].
Further, normal head CTs do not guarantee that severe injury
is not present; initial radiographic findings in diffuse axonal
and global hypoxic injuries may be unremarkable even in a
clinically devastated patient. These scenarios represent a gap
in the ability to detect neuropathological events in the TBI
patient. Improved diagnostic modalities may aid in the
triage, transport, and treatment of victims of acute neurolog-
ical emergencies.
Delayed recognition and treatment of severe TBI may be
harmful. Aggressive airway, ventilatory, and intracranial
pressure management in concert with efficient neurosurgi-
cal decompression and hematoma evacuation may be life
saving. Conversely, endotracheal intubation or use of
osmotic agents for intracranial pressure control in patients
without TBI poses possible harm without potential for
benefit. Improvements in the diagnostic capabilities in this
patient population are needed to better triage resources and
separate those most at-risk from those not at risk.
Meningitis
The diagnosis of meningitis is, in itself, relatively straight-
forward and relies on analysis of cell counts in cerebrospi-
nal fluid samples. Improved technology could speed the
time needed to analyze these samples, but clinical impact
would likely be minimal. Differentiation of meningitis
etiology—bacterial, viral, fungal, or sterile—without await-
ing culture results would have a much larger impact on
clinical care [31]. Anti-infectious agents could be tailored
in an expedient manner, steroids could be given only to
those most likely to benefit, and outpatient management
strategies could be developed for the care of patients at low-
risk of poor outcomes [32].
Current practice is to treat with empiric broad-spectrum
antibiotics and anti-virals for 24–48 h while awaiting CSF
culture results; this therapy is only available as an in-
patient, requiring hospital admission for many patients who
ultimately have non-bacterial, non-HSV meningitis that
require symptomatic support [33]. In developed countries,
approximately 4 per 100,000 persons per year develop
bacterial meningitis, resulting in sizable outlays of mone-
tary and clinical resources [32]. Development of a point-of-
care technology that could quickly differentiate bacterial
from non-bacterial meningitis, for example, could curtail
the current necessary over-triage and over-treatment of
patients with suspected meningitis.
Point-of-care testing
Point-of-care (POC) testing brings advanced diagnostics to
the patient’s bedside in an effort to assist medical providers
with real-time decisions based on real-time information.
POC testing is usually associated with blood tests (blood
glucose, troponin, etc.), but can involve imaging, medical
devices, or adapting existing technologies for use outside of
the hospital. Successful POC testing should impact aspects
of the triage, transport, and/or treatment of the patient.
The care of patients with acute myocardial infarction has
been accelerated by the use of pre-hospital EKGs, greatly
reducing medical contact to balloon times for percutaneous
coronary interventions; paramedic administered fibrino-
lytics have been attempted for decades based on integration
of this POC diagnostic tool [34, 35]. Ultra-sensitive bedside
troponin assays decrease the chance of missed myocardial
infarctions and speed time to therapy in non-ST segment
elevation myocardial infarction patients [36]. Such rapid
testing also allows early identification of subjects for
clinical trials [37].
The care of the septic patient has been revolutionized by
the development of real-time markers of systemic hypo-
perfusion, particularly lactate and central venous oxygen
saturation (SCVO2). The concept of an early goal directed
therapy in sepsis has decreased mortality, in part due to
improved recognition and identification of patients [38].
Lactate clearance and improvement in SCVO2 are objective
measures of response to therapy and assist treating
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vanced to allow continuous measurement of these markers
at the bedside through advanced central catheters [39].
Management of the severely traumatized patient has
improved with the use of bedside ultrasonography. Pneu-
mothorax, pericardial effusion, and hemoperitoneum can be
quickly identified and used to help guide therapy. The
development of smaller and sturdier devices has created a
niche for the out-of-hospital environment, with obvious
implications for EMS, combat casualty care, and disaster
and mass casualty situations [40].
Noticeably missing from the list of current point-of-care
technologies are real-time bedside capabilities that address
neurological emergencies. The most common POC test used
for altered mental status patientsis blood glucose level, which
allows rapid diagnosis and treatment of hypoglycemia or
exclusion of this process from a differential diagnosis.
Continuous EEG monitoring, as discussed above, can be
considered a POC technology. The complexity of EEG
interpretation and time and precision required for proper
electrode placement limit the utility of EEG outside of
controlled and specialized settings. Ultrasonic measurement
of optic nerve sheath diameter is being explored as a POC test
for intracranial hypertension; this field of study is expanding,
but not yet ready tobeapplied in routine clinicalpractice [41–
43]. Unfortunately, the lack of more of these types of
technologies may result in delayed identification of patients
with these devastating conditions and contribute to less
aggressive therapies than are seen with other disease
processes. Development of time-dependent technologies
appropriate for use with the neurologically ill patient is
needed to improve therapies and outcomes.
Current funding opportunities
Development of novel techniques and technologies requires
significant funding, which can be difficult to obtain without
preliminary data. Many investigators rely on intra-mural
funding and donated academic effort to conduct proof-of-
concept pilot studies. While this “bootstrap” approach to
new product initiation can be personally rewarding, such
professional devotion can be an entry barrier for new
investigators. In partial response to this need, the National
Institutes of Health (NIH) have funded the Point-of-Care
Technologies Research Network (POCTRN) [44]. Each
center in the Network is funded to support the development
of point-of-care technologies in a specific clinical area. The
Point-of-Care Center for Emerging Neurologic Technolo-
gies (POC-CENT) at the University of Cincinnati (funded
by grant no. 5-U54-EB007954) is focused towards gener-
ating diagnostics appropriate for acute neurological emer-
gencies where point-of-care information can be obtained.
Like all of the Centers in POCTRN, POC-CENT uses
clinical-needs driven decision making to target both early
stage technological development and pre-clinical assess-
ment of emerging point-of-care technologies. In addition to
supporting projects that are internal to the Center, POC-
CENT can fund external research and/or work as a
collaborator with research scientists and clinicians to
develop new technology concepts. Any entity that is
eligible for NIH funding including faculty, post docs,
residents, and corporate industry can be supported by
POC-CENT.
POC-CENT is designed to support the development of
novel ideas focused on improving diagnostic or prognostic
capabilities for acute neurological emergencies. Eligible
examples include biomarkers of traumatic brain injury, non-
invasive measurements of intracranial pressure or cerebral
vasospasm, and improved detection of pathological bacteria
in suspected meningitis.
Conclusion
Acute neurological emergencies pose a significant threat to
the life and independence of every person. Often, such
emergencies strike without warning, and medical care must
be provided as soon as possible to minimize significant and
permanent functional impairments. Currently, unavoidable
delays required to obtain confirmatory testing impact the
speed at which this time-critical care can be delivered. POC
technologies that impact the triage, transport, or treatment
of these patients are critically needed. As creative scientists
and clinicians imagine ways to improve diagnostic techni-
ques, POC-CENTexists to support and enable the transition
from invention to intervention.
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